Bioavailability

As per available reports about 25 journals, 16 Conferences and 10 Workshops are presently dedicated exclusively to Bioavailability and about 36 articles are being published on the current trends in Bioavailability. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to bioavailability are being carried out. As reported in above mentioned article, In pharmacology, Bioavailability (BA) is a subcategory of absorption and is the fraction of an administered dose of unchanged drug that reaches the systemic circulation, one of the principal pharmacokinetic properties of drugs. By definition, when a medication is administered intravenously, its bioavailability is 100%. However, when a medication is administered via other routes (such as orally), its bioavailability generally TH decreases (due to incomplete absorption and first-pass metabolism) or may vary from patient to patient. Bioavailability is one of the essential tools in pharmacokinetics, as bioavailability must be considered when calculating dosages for non-intravenous routes of administration.

The Journal of Bioequivalence & Bioavailability is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in Bioavailability. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Bioequivalence & Bioavailability provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of Bioavailability and bioequivalence, thus bridging the gap between researchers and young scientists.

OMICS International cordially invites all the participants across the globe to attend the 7^th World Congress on Bioavailabity & Bioequivalence: BA/BE Studies Summit during Aug 29 - Aug 31, 2016 at Atlanta, USA. Bioavailability and bioequivalence World Congress 2016 is a platform for various people from pharmaceutical backgrounds, HealthCare institutions, Pharmaceutical regulatory agencies, Biotech and Clinical Research organizations. The main theme of the World Congress meeting is “Innovative Approaches of BA/BE to Revolutionize the Next Generation Medicine”. We make sure that scientists and researchers get the popularity and rewards that they be and also the chance to play a big role within the international scientific community.